Company overview
Almaject® is focused on the development, acquisition, and commercialization of injectable generic pharmaceutical products. The current portfolio of injectables covers a broad range of therapeutic areas. Our commercial, business development, and R&D teams are creating new opportunities to expand our portfolio into complex molecules.
Alvogen Core Businesses include:
Almaject
Focusing on injectable generic pharmaceutical products.
Almatica brand products
Focusing on branded pharmaceutical products.
Alvogen generic business
Focusing on generic pharmaceutical products for the United States, Europe, Asia and Latin America.
Norwich US-based manufacturing
In-house manufacturing capabilities include finished dosage form including solid oral dosage, soft gelatin capsules, modified release tablets, transdermals, creams, ointments and injectables.
For additional information, visit www.alvogen.com